
AMED
Asia, Tokyo, Japan, Tokyo
Description
Japan Agency for Medical Research and Development is an independent japanese medical research and development organization.
Investor Profile
AMED has backed more than 6 startups, with 5 new investments in the last 12 months alone. The firm has led 5 rounds, about 83% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Corporate Round rounds (top funding stages).
- Majority of deals are located in Japan, United States.
- Strong thematic focus on Health Care, Biotechnology, Therapeutics.
- Led 5 rounds in the past year.
Stage Focus
- Grant (83%)
- Corporate Round (17%)
Country Focus
- Japan (50%)
- United States (50%)
Industry Focus
- Health Care
- Biotechnology
- Therapeutics
- Business Information Systems
- Document Management
- Information Services
- Manufacturing
- Alternative Medicine
- Clinical Trials
- Outpatient Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.